Here, we specified the significant hypomethylation of F2RL3 in the blood leukocyte DNA of MI and heart failure CHD cases compared to controls and suggested its potential clinical application as a biomarker for the prediction of MI and heart failure. This evidence concerns the gene F2RL3 and heart failure.